Deep dive #12 · 20 November 2026

Hypermobility: hEDS, hypermobility spectrum disorders and the EDS family

For health professionals Genetics and rheumatology Chronic pain

Bendy joints are common, mostly harmless and occasionally the visible tip of a dangerous collagen gene. hEDS is the commonest named type, yet it is the only one with no gene, criteria that are being rewritten, and an internet reputation that has outrun the evidence. The useful clinical job is twofold: spot the rare vascular patient who must not be missed, and give everyone else a diagnosis, strength work and fewer opioids.

At a glance

Biggest take-home: screen for vascular red flags once, then treat function. Strength and proprioceptive training, pacing and pain education beat a hunt for the perfect label or a fourth opioid.

For patients: Ehlers-Danlos syndromes and hypermobility, POTS, MCAS and Chronic pain. For clinicians: the POTS and ME/CFS deep dives.

Definition

History

Pathophysiology

For the genetic types, the pathway runs from gene to faulty collagen or matrix processing. For hEDS and HSD the mechanism is unknown; what follows are findings, not a model.

Epidemiology

Causes and risk factors

Preventable factors

Diagnosis essentials

Symptomatic hypermobilitypain, instability, subluxationsRed flags? Refer to geneticsrupture, fragile skin, family sudden deathCriterion 1: generalised laxityBeighton ≥6 child · ≥5 to 50 · ≥4 over 50Criterion 2: ≥2 of A, B, CA ≥5/12 signs · B relative · C pain/instabilityCriterion 3: exclusionsno skin fragility; other causes ruled outall metnot methEDSclinical diagnosisno gene test yetHSDgeneralised, peripheral,localised, historical
Assessing symptomatic hypermobility with the 2017 criteria (simplified from Malfait 2017 and Castori 2017). New criteria are due in 2027. Download this diagram

Current treatment

No drug treats hEDS or HSD. The evidence for rehabilitation is small, short and mostly in women; it is still the best we have.

Rehabilitation

Pain, fatigue and the rest

Pregnancy

Emerging treatments and trials

Theoretical frontiers

Hypotheses, not recommendations.

Causes: theories

Prevention: theoretical options

Treatment: theoretical options

Gaps and open questions

Prognosis and quality of life

Weird trivia

Guidelines

Key trials

Sources

Information only. Check product information, PBS criteria and current Australian guidelines before prescribing. No medicine is TGA-approved for hEDS or HSD; medicines above are used off-label.

Updated 20 November 2026. General education for health professionals; not a substitute for local protocols.